126 related articles for article (PubMed ID: 22806367)
1. Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation.
Carboni N; Sardu C; Cocco E; Marrosu G; Manzi RC; Nissardi V; Isola F; Mateddu A; Solla E; Maioli MA; Oppo V; Piras R; Coghe G; Lai C; Marrosu MG
Muscle Nerve; 2012 Aug; 46(2):187-92. PubMed ID: 22806367
[TBL] [Abstract][Full Text] [Related]
2. Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.
van Rijsingen IA; Nannenberg EA; Arbustini E; Elliott PM; Mogensen J; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Grasso M; Serio A; Jenkins S; Rowland C; Richard P; Wilde AA; Perrot A; Pankuweit S; Zwinderman AH; Charron P; Christiaans I; Pinto YM
Eur J Heart Fail; 2013 Apr; 15(4):376-84. PubMed ID: 23183350
[TBL] [Abstract][Full Text] [Related]
3. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation.
Hershberger RE; Hanson EL; Jakobs PM; Keegan H; Coates K; Bousman S; Litt M
Am Heart J; 2002 Dec; 144(6):1081-6. PubMed ID: 12486434
[TBL] [Abstract][Full Text] [Related]
4. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.
Charniot JC; Pascal C; Bouchier C; Sébillon P; Salama J; Duboscq-Bidot L; Peuchmaurd M; Desnos M; Artigou JY; Komajda M
Hum Mutat; 2003 May; 21(5):473-81. PubMed ID: 12673789
[TBL] [Abstract][Full Text] [Related]
6. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
[TBL] [Abstract][Full Text] [Related]
7. Novel c.367_369del LMNA mutation manifesting as severe arrhythmias, dilated cardiomyopathy, and myopathy.
Keller H; Finsterer J; Steger C; Wexberg P; Gatterer E; Khazen C; Stix G; Gerull B; Höftberger R; Weidinger F
Heart Lung; 2012; 41(4):382-6. PubMed ID: 22019351
[TBL] [Abstract][Full Text] [Related]
8. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
[TBL] [Abstract][Full Text] [Related]
9. R25G mutation in exon 1 of LMNA gene is associated with dilated cardiomyopathy and limb-girdle muscular dystrophy 1B.
Yuan WL; Huang CY; Wang JF; Xie SL; Nie RQ; Liu YM; Liu PM; Zhou SX; Chen SQ; Huang WJ
Chin Med J (Engl); 2009 Dec; 122(23):2840-5. PubMed ID: 20092787
[TBL] [Abstract][Full Text] [Related]
10. Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects.
Hasselberg NE; Edvardsen T; Petri H; Berge KE; Leren TP; Bundgaard H; Haugaa KH
Europace; 2014 Apr; 16(4):563-71. PubMed ID: 24058181
[TBL] [Abstract][Full Text] [Related]
11. Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations.
Carboni N; Mura M; Marrosu G; Cocco E; Marini S; Solla E; Mateddu A; Maioli MA; Piras R; Mallarini G; Mercuro G; Porcu M; Marrosu MG
Muscle Nerve; 2010 Apr; 41(4):458-63. PubMed ID: 19882644
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome and risk stratification in dilated cardiolaminopathies.
Pasotti M; Klersy C; Pilotto A; Marziliano N; Rapezzi C; Serio A; Mannarino S; Gambarin F; Favalli V; Grasso M; Agozzino M; Campana C; Gavazzi A; Febo O; Marini M; Landolina M; Mortara A; Piccolo G; Viganò M; Tavazzi L; Arbustini E
J Am Coll Cardiol; 2008 Oct; 52(15):1250-60. PubMed ID: 18926329
[TBL] [Abstract][Full Text] [Related]
13. Dilated cardiomyopathy with profound segmental wall motion abnormalities and ventricular arrhythmia caused by the R541C mutation in the LMNA gene.
Saj M; Jankowska A; Lewandowski M; Szwed H; Szperl M; Płoski R; Bilińska ZT
Int J Cardiol; 2010 Oct; 144(3):e51-3. PubMed ID: 19167105
[TBL] [Abstract][Full Text] [Related]
14. Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.
Millat G; Bouvagnet P; Chevalier P; Sebbag L; Dulac A; Dauphin C; Jouk PS; Delrue MA; Thambo JB; Le Metayer P; Seronde MF; Faivre L; Eicher JC; Rousson R
Eur J Med Genet; 2011; 54(6):e570-5. PubMed ID: 21846512
[TBL] [Abstract][Full Text] [Related]
15. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.
van Rijsingen IA; Arbustini E; Elliott PM; Mogensen J; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Pilotto A; Pasotti M; Jenkins S; Rowland C; Aslam U; Wilde AA; Perrot A; Pankuweit S; Zwinderman AH; Charron P; Pinto YM
J Am Coll Cardiol; 2012 Jan; 59(5):493-500. PubMed ID: 22281253
[TBL] [Abstract][Full Text] [Related]
18. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
19. [Cardiac manifestations of laminopathies].
Brette S; Penisson-Besnier I; Dupuis JM; Bonne G; Victor J
Arch Mal Coeur Vaiss; 2004 Oct; 97(10):973-7. PubMed ID: 16008174
[TBL] [Abstract][Full Text] [Related]
20. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
